Rick E Winningham
2009 - Innoviva
In 2009, Rick E Winningham earned a total compensation of $2.3M as Chief Executive Officer at Innoviva, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $336,945 |
|---|---|
| Salary | $791,516 |
| Stock Awards | $1,172,000 |
| Other | $148 |
| Total | $2,300,609 |
Winningham received $1.2M in stock awards, accounting for 51% of the total pay in 2009.
Winningham also received $336.9K in non-equity incentive plan, $791.5K in salary and $148 in other compensation.
Rankings
In 2009, Rick E Winningham's compensation ranked 2,067th out of 9,885 executives tracked by ExecPay. In other words, Winningham earned more than 79.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,067 out of 9,885 | 79th |
Division Manufacturing | 724 out of 3,690 | 80th |
Major group Chemicals And Allied Products | 137 out of 866 | 84th |
Industry group Drugs | 83 out of 638 | 87th |
Industry Pharmaceutical Preparations | 65 out of 446 | 85th |
Source: SEC filing on April 16, 2012.
Winningham's colleagues
We found four more compensation records of executives who worked with Rick E Winningham at Innoviva in 2009.
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019